Literature DB >> 32713336

Chloroquine as chemoprophylaxis for COVID-19: Will this work?

Sherief Abd-Elsalam1, Mahmoud Elkadeem1, Khadija Ahmed Glal2.   

Abstract

Entities:  

Keywords:  Chemoprophylaxis; Global; Malaria; Pandemic; SARS; SARS-COV-2; Viruses

Year:  2020        PMID： 32713336     DOI： 10.2174/1871526520666200726224802

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN： 1871-5265


× No keyword cloud information.
  4 in total

1.  Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome.

Authors:  Rana Kadry; Andrea Sikora Newsome; Payaningal R Somanath
Journal:  Infect Disord Drug Targets       Date:  2021

2.  Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial.

Authors:  Sherief Abd-Elsalam; Shaimaa Soliman; Eslam Saber Esmail; Mai Khalaf; Ehab F Mostafa; Mohammed A Medhat; Ossama Ashraf Ahmed; Mohamed Samir Abd El Ghafar; Mohamed Alboraie; Sahar M Hassany
Journal:  Biol Trace Elem Res       Date:  2020-11-27       Impact factor: 3.738

3.  Reimagining Innovation Amid the COVID-19 Pandemic: Insights From the WISH Innovation Programme.

Authors:  Maha El Akoum; Mahmoud El Achi
Journal:  Front Public Health       Date:  2021-06-07

4.  Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.

Authors:  Sherief Abd-Elsalam; Eslam Saber Esmail; Mai Khalaf; Ehab Fawzy Abdo; Mohammed A Medhat; Mohamed Samir Abd El Ghafar; Ossama Ashraf Ahmed; Shaimaa Soliman; Ghada N Serangawy; Mohamed Alboraie
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.